Paloma Partners Management CO Protalix Bio Therapeutics, Inc. Call Options Transaction History
Paloma Partners Management CO
- $1.69 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PLX
# of Institutions
50Shares Held
4.58MCall Options Held
40.9KPut Options Held
5.3K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.12MShares$2.6 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL732KShares$1.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny388KShares$903,8550.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$776,2880.0% of portfolio
-
Gsa Capital Partners LLP London, X0306KShares$712,3950.04% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $116M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...